Pilz Bioscience
The Pilz Approach
Pilz Bioscience Corp. (“Pilz”) is a biotechnology company developing medicinal psychedelics for neuroinflammatory conditions with a significant cognitive component and high unmet therapeutic needs. The initial focus is on Autism Spectrum Disorder (ASD). The company intends to leverage a unique systems-level scientific approach that integrates inflammation, oral/gut/brain axis, and behavior. Pilz aims to lead the global effort in design of effective and comprehensive diagnostic/monitoring programs and first-in-class therapeutics.
What are medicinal psychedelics
Forefront of a Medical Revolution
  • Chemical compounds such as psilocybin (4-phosphoryloxy-N,N-dimethyltryptamine) derived from certain species of hallucinogenic mushrooms

  • Powerful behavioral agents at the forefront of a medical revolution, integrating cellular function and inflammation with cognition and mental health

  • Agonists at serotonin receptors with the ability to modulate psychological states

  • Ideal drug candidates for inflammatory neurological conditions with a significant cognitive component

Why patients need a new approach
A Bridge Between Disciplines
  • One thing that doesn’t work in modern western healthcare is separating cellular function from cognition and behavior, with different specialists handling patient care

  • Addressing the true complexity of neurological conditions, medicinal psychedelics integrate biological markers of brain function with mood, cognition, and behavior

  • The medical community is increasingly open to exploring the therapeutic potential of psychedelics in neuroinflammatory conditions

How Pilz leadership will succeed
Proprietary Technology, Top-level Talent
  • Expertise in drug discovery and development, including proprietary drug manufacturing, preclinical model systems, and clinical testing

  • Robust knowledge of world-wide regulatory affairs, commercialization strategy, and finance

  • Subject-matter expertise in autism, neural injury, genome research, metabolic analysis, microbiotic profiling, and computational analytics

Pilz Bioscience
Clinical Innovation

The Pilz integrative approach is to develop a diagnostic and therapeutic index for conditions with unmet medical needs.  Pilz scientists are building a platform that integrates genetic risk factors, inflammatory/immune indices, and microbiome data into a computational model.

Initially targeting Autism Spectrum Disorders (ASD), Pilz is developing the ‘ASD Correlate’ – a statistical score for modeling diagnostics and therapeutics. Explore the ASD Correlate